BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11092551)

  • 1. 3-D QSAR analysis of inhibition of murine soluble epoxide hydrolase (MsEH) by benzoylureas, arylureas, and their analogues.
    Nakagawa Y; Wheelock CE; Morisseau C; Goodrow MH; Hammock BG; Hammock BD
    Bioorg Med Chem; 2000 Nov; 8(11):2663-73. PubMed ID: 11092551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the structure of urea-like compounds as inhibitors of the juvenile hormone epoxide hydrolase (JHEH) of the tobacco hornworm Manduca sexta: analysis of the binding modes and structure-activity relationships of the inhibitors by docking and CoMFA calculations.
    Garriga M; Caballero J
    Chemosphere; 2011 Mar; 82(11):1604-13. PubMed ID: 21134691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of alkylurea inhibitors to epoxide hydrolase implicates active site tyrosines in substrate activation.
    Argiriadi MA; Morisseau C; Goodrow MH; Dowdy DL; Hammock BD; Christianson DW
    J Biol Chem; 2000 May; 275(20):15265-70. PubMed ID: 10747889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis.
    Gomez GA; Morisseau C; Hammock BD; Christianson DW
    Biochemistry; 2004 Apr; 43(16):4716-23. PubMed ID: 15096040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classical and three-dimensional QSAR for the inhibition of [3H]ponasterone A binding by diacylhydrazine-type ecdysone agonists to insect Sf-9 cells.
    Nakagawa Y; Takahashi K; Kishikawa H; Ogura T; Minakuchi C; Miyagawa H
    Bioorg Med Chem; 2005 Feb; 13(4):1333-40. PubMed ID: 15670941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-QSAR of human immunodeficiency virus (I) protease inhibitors. III. Interpretation of CoMFA results.
    Opera TI; Waller CL; Marshall GR
    Drug Des Discov; 1994 Jul; 12(1):29-51. PubMed ID: 7578806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design based on bioactive conformation analysis of pyrimidinylbenzoates as acetohydroxyacid synthase inhibitors by integrating molecular docking, CoMFA, CoMSIA, and DFT calculations.
    He YZ; Li YX; Zhu XL; Xi Z; Niu C; Wan J; Zhang L; Yang GF
    J Chem Inf Model; 2007; 47(6):2335-44. PubMed ID: 17887745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase.
    Kim IH; Park YK; Nishiwaki H; Hammock BD; Nishi K
    Bioorg Med Chem; 2015 Nov; 23(22):7199-210. PubMed ID: 26507430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D-QSAR analysis on benzazole derivatives as eukaryotic topoisomerase II inhibitors by using comparative molecular field analysis method.
    Temiz-Arpaci O; Tekiner-Gulbas B; Yildiz I; Aki-Sener E; Yalcin I
    Bioorg Med Chem; 2005 Dec; 13(23):6354-9. PubMed ID: 15993083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme.
    Adane L; Bharatam PV
    J Mol Graph Model; 2009 Nov; 28(4):357-67. PubMed ID: 19796975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.
    Anandan SK; Gless RD
    Bioorg Med Chem Lett; 2010 May; 20(9):2740-4. PubMed ID: 20363133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors.
    Takai K; Chiyo N; Nakajima T; Nariai T; Ishikawa C; Nakatani S; Ikeno A; Yamamoto S; Sone T
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1705-1708. PubMed ID: 25800114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
    Morisseau C; Goodrow MH; Dowdy D; Zheng J; Greene JF; Sanborn JR; Hammock BD
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):8849-54. PubMed ID: 10430859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase.
    Jones PD; Tsai HJ; Do ZN; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5212-6. PubMed ID: 16870439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Photorhabdus natural product inhibits insect juvenile hormone epoxide hydrolase.
    Nollmann FI; Heinrich AK; Brachmann AO; Morisseau C; Mukherjee K; Casanova-Torres ÁM; Strobl F; Kleinhans D; Kinski S; Schultz K; Beeton ML; Kaiser M; Chu YY; Phan Ke L; Thanwisai A; Bozhüyük KA; Chantratita N; Götz F; Waterfield NR; Vilcinskas A; Stelzer EH; Goodrich-Blair H; Hammock BD; Bode HB
    Chembiochem; 2015 Mar; 16(5):766-71. PubMed ID: 25711603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis.
    Du F; Sun W; Morisseau C; Hammock BD; Bao X; Liu Q; Wang C; Zhang T; Yang H; Zhou J; Xiao W; Liu Z; Chen G
    Eur J Med Chem; 2021 Nov; 223():113678. PubMed ID: 34218083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors.
    Hwang SH; Morisseau C; Do Z; Hammock BD
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5773-7. PubMed ID: 16949285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptidyl-urea based inhibitors of soluble epoxide hydrolases.
    Morisseau C; Newman JW; Tsai HJ; Baecker PA; Hammock BD
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5439-44. PubMed ID: 16908134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinazoline-4(3H)-one derivatives as novel and potent inhibitors of soluble epoxide hydrolase: Design, synthesis and biological evaluation.
    Hejazi L; Rezaee E; Tabatabai SA
    Bioorg Chem; 2020 Jun; 99():103736. PubMed ID: 32229350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of polar spirocyclic orally bioavailable urea inhibitors of soluble epoxide hydrolase.
    Lukin A; Kramer J; Hartmann M; Weizel L; Hernandez-Olmos V; Falahati K; Burghardt I; Kalinchenkova N; Bagnyukova D; Zhurilo N; Rautio J; Forsberg M; Ihalainen J; Auriola S; Leppänen J; Konstantinov I; Pogoryelov D; Proschak E; Dar'in D; Krasavin M
    Bioorg Chem; 2018 Oct; 80():655-667. PubMed ID: 30059891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.